QC
BIIB icon

Quent Capital’s Biogen BIIB Stock Holding History

Quent Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.6K Sell
85
-4
-4% -$737 ﹤0.01% 1059
2025
Q4 		$15.7K Buy
89
+7
+9% +$1.14K ﹤0.01% 1056
2025
Q3 		$11.5K Buy
+82
New +$11.1K ﹤0.01% 983
2025
Q2 		– Sell
-391
Closed -$53.5K – 390
2025
Q1 		$53.5K Buy
391
+93
+31% +$13.3K 0.01% 539
2024
Q4 		$45.6K Buy
298
+72
+32% +$12.1K ﹤0.01% 603
2024
Q3 		$43.9K Sell
226
-69
-23% -$14.4K ﹤0.01% 702
2024
Q2 		$68.4K Buy
295
+40
+16% +$8.69K 0.01% 573
2024
Q1 		$55K Sell
255
-82
-24% -$19.2K 0.01% 640
2023
Q4 		$87.2K Buy
337
+49
+17% +$12K 0.01% 484
2023
Q3 		$74K Sell
288
-4
-1% -$1.07K 0.01% 492
2023
Q2 		$83.2K Buy
292
+7
+2% +$2.08K 0.01% 466
2023
Q1 		$79.2K Buy
285
+7
+3% +$1.94K 0.01% 469
2022
Q4 		$77K Buy
278
+23
+9% +$6.5K 0.01% 471
2022
Q3 		$68K Buy
255
+25
+11% +$5.31K 0.01% 463
2022
Q2 		$47K Buy
230
+35
+18% +$7.16K 0.01% 531
2022
Q1 		$41K Sell
195
-125
-39% -$27.2K 0.01% 644
2021
Q4 		$77K Buy
+320
New +$82.3K 0.02% 456

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Quent Capital's BIIB Position: Q1 2026 in Review

Quent Capital reduced its Biogen (BIIB) stake by 4.5% in Q1 2026, selling an estimated $737 and leaving 85 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1059.

Quent Capital first reported a position in BIIB in Q4 2021 and has held it in 17 quarters since. The position peaked at $87.2K in Q4 2023. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Quent Capital held 85 shares of Biogen worth $15.6K as of Q1 2026.
  • Quent Capital sold 4 Biogen shares in Q1 2026, an estimated $737.
  • Biogen made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #1059 holding.
  • Quent Capital first reported a position in Biogen in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's Biogen position peaked at $87.2K in Q4 2023.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.